Design Therapeutics (DSGN) Q4 2023 Earnings

19MarConfirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-0.41
-0.34
-0.28
-0.21

Details

Expected EPS
-0.31
Actual EPS
-0.21
Surprise EPS
0.1
Surprise Percent
+32.26%

Description

Design Therapeutics (DSGN) has reported earnings of -0.21 per share for Q4 2023.

0 Comments

Share your thoughts